| dc.contributor.author | Polizo, Antonina | |
| dc.contributor.author | Corlăteanu, Alexandru | |
| dc.contributor.author | Brocovschii, Victoria | |
| dc.date.accessioned | 2026-03-17T13:20:53Z | |
| dc.date.available | 2026-03-17T13:20:53Z | |
| dc.date.issued | 2026 | |
| dc.identifier.citation | POLIZO, Antonina; Alexandru CORLĂTEANU and Victoria BROCOVSCHII. Stevens - Johnson syndrome as a manifestation of drug hypersensitivity reaction. In: Medicina internă în tranziţie de la medicina bazată pe dovezi la medicina personalizată. Chişinău, 2026, p. 139. ISBN 978-9975-82-457-6. (Congresul aniversar „80 de ani de inovaţie în sănătate şi educaţie medicală”, 20-22 octombrie 2025: culegere de rezumate). | en_US |
| dc.identifier.isbn | 978-9975-82-457-6 | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/32871 | |
| dc.description.abstract | Background. Stevens-Johnson Syndrome (SJS) is a rare but severe immune-mediated adverse drug reaction. It falls under the category of delayed hypersensitivity reactions and is characterized by the detachment of the epidermis and mucous membranes. Medications are the most common cause of Stevens-Johnson Syndrome. Objective(s). We aimed to present a detailed clinical case of Stevens-Johnson syndrome that occurred in a 40-year-old patient, following the administration of an antibiotic from the fluoroquinolone class. Materials and methods. A 40-year-old patient undergoing treatment with levofloxacin prescribed for otitis, admitted to the General Therapy and Allergology Department of the Timofei Moșneaga Republican Clinical Hospital on day 3 of treatment, with extensive cutaneo-mucous lesions characteristic of a severe cutaneous adverse reaction (SCAR). Results. A 40-year-old patient, with no history of allergies, presents with generalized maculopapular rash, bullae, mucosal erosions, on day 3 of levofloxacin treatment for otitis. The cutaneous and mucosal manifestations were consistent with a severe drug-induced cutaneous adverse reaction. Laboratory investigations revealed an inflammatory syndrome with increased C-reactive protein and circulating immune complexes, both elevated threefold. Treatment included replacing levofloxacin with alternatives from other classes of antibiotics, systemic (prednisolone 0.5–1.0 mg/kg) and topical corticosteroids, with positive evolution. Conclusion(s). SJS is a rare but severe condition that is frequently caused by medications. In rare cases, fluoroquinolones can cause delayed hypersensitivity reactions. It must be treated immediately in the hospital. Early recognition of symptoms and correct treatment are essential. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | CEP Medicina | en_US |
| dc.relation.ispartof | Medicina internă în tranziţie de la medicina bazată pe dovezi la medicina personalizată: Congresul aniversar „80 de ani de inovaţie în sănătate şi educaţie medicală”, 20-22 octombrie 2025: Culegere de rezumate | en_US |
| dc.subject | delayed hypersensitivity | en_US |
| dc.subject | SJS | en_US |
| dc.subject | levofloxacin | en_US |
| dc.subject | allergy | en_US |
| dc.title | Stevens - Johnson syndrome as a manifestation of drug hypersensitivity reaction | en_US |
| dc.type | Other | en_US |